These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145 [TBL] [Abstract][Full Text] [Related]
3. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. Tsuchida T; Lee YA; Fujiwara N; Ybanez M; Allen B; Martins S; Fiel MI; Goossens N; Chou HI; Hoshida Y; Friedman SL J Hepatol; 2018 Aug; 69(2):385-395. PubMed ID: 29572095 [TBL] [Abstract][Full Text] [Related]
4. A Mouse Model of Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Induced by Western Diet and Carbon Tetrachloride. Li S; Motiño O; Lambertucci F; Chen H; Anagnostopoulos G; Montégut L; Nogueira-Recalde U; Maiuri MC; Kroemer G; Martins I Methods Mol Biol; 2024; 2769():57-65. PubMed ID: 38315388 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624 [TBL] [Abstract][Full Text] [Related]
6. A short-term rodent model for non-alcoholic steatohepatitis induced by a high-fat diet and carbon tetrachloride. Araujo LCC; Dias CCB; Sucupira FG; Ramalho LNZ; Camporez JP Biosci Rep; 2024 May; 44(5):. PubMed ID: 38660995 [TBL] [Abstract][Full Text] [Related]
8. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis. Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204 [TBL] [Abstract][Full Text] [Related]
9. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112 [TBL] [Abstract][Full Text] [Related]
10. Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway. Wang MY; Zhang SS; An MF; Xia YF; Fan MS; Sun ZR; Zhang LJ; Zhao YL; Sheng J; Wang XJ Phytomedicine; 2023 Jun; 114():154798. PubMed ID: 37031639 [TBL] [Abstract][Full Text] [Related]
11. A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology. van den Hoek AM; Verschuren L; Worms N; van Nieuwkoop A; de Ruiter C; Attema J; Menke AL; Caspers MPM; Radhakrishnan S; Salic K; Kleemann R Cells; 2020 Sep; 9(9):. PubMed ID: 32883049 [TBL] [Abstract][Full Text] [Related]
12. Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice. Li J; Liu C; Zhou Z; Dou B; Huang J; Huang L; Zheng P; Fan S; Huang C Phytother Res; 2021 Jun; 35(6):3351-3364. PubMed ID: 33784797 [TBL] [Abstract][Full Text] [Related]
13. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD. Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487 [TBL] [Abstract][Full Text] [Related]
14. Activation of the NLRP3 inflammasome by CCl Vargas-Pozada EE; Ramos-Tovar E; Rodriguez-Callejas JD; Cardoso-Lezama I; Galindo-Gómez S; Gil-Becerril K; Vásquez-Garzón VR; Arellanes-Robledo J; Tsutsumi V; Villa-Treviño S; Muriel P Ann Hepatol; 2023; 28(1):100780. PubMed ID: 36309184 [TBL] [Abstract][Full Text] [Related]
16. Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. Rahman K; Desai C; Iyer SS; Thorn NE; Kumar P; Liu Y; Smith T; Neish AS; Li H; Tan S; Wu P; Liu X; Yu Y; Farris AB; Nusrat A; Parkos CA; Anania FA Gastroenterology; 2016 Oct; 151(4):733-746.e12. PubMed ID: 27342212 [TBL] [Abstract][Full Text] [Related]
17. The Influence of Emodin Succinyl Ethyl Ester on Non-alcoholic Steatohepatitis Induced by a Diet High in Fructose, Cholesterol, and Fat in Mice. Wang Y; Li L; Chen L; Xia J; Wang T; Han L; Cao L; Wang Z; Xiao W; Jiang S Biol Pharm Bull; 2024 May; 47(5):978-987. PubMed ID: 38631865 [TBL] [Abstract][Full Text] [Related]
18. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis. Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934 [TBL] [Abstract][Full Text] [Related]
19. Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol. Henkel J; Coleman CD; Schraplau A; Jӧhrens K; Weber D; Castro JP; Hugo M; Schulz TJ; Krämer S; Schürmann A; Püschel GP Mol Med; 2017 May; 23():70-82. PubMed ID: 28332698 [TBL] [Abstract][Full Text] [Related]
20. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway. Xie Y; Jin Y; Wen J; Li G; Huai X; Duan Y; Ni F; Fu J; Li M; Li L; Yan M; Cao L; Xiao W; Yang H; Wang ZZ Biomed Pharmacother; 2024 Jul; 176():116908. PubMed ID: 38850668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]